P.F. Bruning - Concepedia

Author

P.F. Bruning

Also Known As

P Bruning, P F Bruning, P. Bruning, P. F. BRUNING, P. F. Bruning, P.F Bruning, P.F. BRUNING, P.F. Bruning, Patrick Bruning

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

The Netherlands Cancer Institute Institut Jules Bordet Amsterdam UMC Location University of Amsterdam Universitair Ziekenhuis Leuven

About

P.F. Bruning is an author at The Netherlands Cancer Institute specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	26	1.5K
2	Public Health	7	7	330
3	Health Sciences	5	5	367
4	Clinical Nutrition	2	2	36
5	Biomedical Engineering	1	1	24

P.F. Bruning

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Paclitaxel Versus Doxorubicin as First-Line Single-Agent Chemotherapy for Metastatic Breast Cancer: A European Organization for Research and Treatment of Cancer Randomized Study With Cross-Over Robert Paridaens, Laura Biganzoli, P.F. Bruning, Journal of Clinical Oncology	2000	355
Doxorubicin and Paclitaxel Versus Doxorubicin and Cyclophosphamide as First-Line Chemotherapy in Metastatic Breast Cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial Laura Biganzoli, Tanja Čufer, P.F. Bruning, Journal of Clinical Oncology	2002	216
Body fat mass, body fat distribution, and pubertal development: a longitudinal study of physical and hormonal sexual maturation of girls. C. M. de Ridder, J.H.H. Thijssen, P.F. Bruning, The Journal of Clinical Endocrinology & Metabolism Physical HealthObesityBody Fat MassBody CompositionFertility	1992	188
Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer Jocelyn Kramer, Desmond Curran, Martine Piccart, European Journal of Cancer Advanced Breast CancerBreast OncologyOncologyLife Prognostic FactorsCancer Management	2000	166
Body Fat Mass, Body Fat Distribution, and Plasma Hormones in Early Puberty in Females C. M. de Ridder, P.F. Bruning, Maria L. Zonderland, The Journal of Clinical Endocrinology & Metabolism NutritionGynecologyFemale Reproductive FunctionAdipokinesObesity	1990	137
MAM-6 antigen, a new serum marker for breast cancer monitoring. John Hilkens, V. Kroezen, J. M. G. Bonfrer, PubMed Biomarker (Medicine)Iv Breast CancerBreast OncologyOncologyCancer Detection	1986	132
The quality of life of long-term survivors of Hodgkin's disease Maurits W. van Tulder, Neil K. Aaronson, P.F. Bruning Annals of Oncology Quality Of LifeLife AssessmentDisease ProgressionLongevityTerminal Illness	1994	131
Relation of Serum Levels of Testosterone and Dehydroepiandrosterone Sulfate to Risk of Breast Cancer in Postmenopausal Women Anne Zeleniuch‐Jacquotte, P.F. Bruning, Johannes M.G. Bonfrèr, American Journal of Epidemiology	1997	118
Body measurements, estrogen availability and the risk of human breast cancer: A case‐control study P.F. Bruning, Johannes M.G. Bonfrèr, A.A.M. Hart, International Journal of Cancer NutritionBreast OncologyNutritional EpidemiologyBody MeasurementsCardiometabolic Risk	1992	116
EORTC 10968: a phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx®, Doxil®) at a 6-week interval in patients with metastatic breast cancer Anne Hamilton, Laura Biganzoli, Robert E. Coleman, Annals of Oncology Metastatic Breast CancerOncology6-Week IntervalBreast OncologyMedicine	2002	105

Page 1